Literature DB >> 15527710

Hepatitis A.

Miguel R Arguedas1, Michael B Fallon.   

Abstract

Hepatitis A infection is typically transmitted by the fecal-oral route. Symptomatic infection is highly dependent on the age of the patient and usually follows a self-limited course. Once diagnosed, clinical and biochemical follow-up in the outpatient setting is generally appropriate. Treatment aims are to achieve symptomatic relief and to maintain adequate hydration and caloric intake. In patients with more severe disease, hospitalization may be needed to accomplish aggressive symptomatic therapy and close monitoring of liver function tests and mental status. Prompt evaluation for liver transplantation is appropriate in the rare case where fulminant liver failure develops. Given the absence of specific therapy for hepatitis A virus infection, the most important health care intervention is prevention of infection and/or transmission, which can be accomplished with the safe and effective use of immune globulin and commercially available vaccines.

Entities:  

Year:  2004        PMID: 15527710     DOI: 10.1007/s11938-004-0003-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  32 in total

Review 1.  ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis.

Authors:  S D Ryder; I J Beckingham
Journal:  BMJ       Date:  2001-01-20

2.  Immunogenicity of hepatitis A vaccine in decompensated liver disease.

Authors:  J A Dumot; D S Barnes; Z Younossi; S M Gordon; R K Avery; R E Domen; J M Henderson; W D Carey
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

3.  Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.

Authors:  B L Wiens; N R Bohidar; J G Pigeon; J Egan; W Hurni; L Brown; B J Kuter; D R Nalin
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

Review 4.  Atypical clinical manifestations of hepatitis A.

Authors:  E R Schiff
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

5.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1994-01-28

Review 6.  Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs.

Authors:  Matthew G Deneke; Miguel R Arguedas
Journal:  Expert Rev Vaccines       Date:  2003-10       Impact factor: 5.217

Review 7.  Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?

Authors:  E B Keeffe
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

8.  Acute pancreatitis associated with acute hepatitis A in a young child.

Authors:  L A Shrier; S J Karpen; C McEvoy
Journal:  J Pediatr       Date:  1995-01       Impact factor: 4.406

9.  The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies.

Authors:  B P Bell; C N Shapiro; M J Alter; L A Moyer; F N Judson; K Mottram; M Fleenor; P L Ryder; H S Margolis
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

10.  An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.

Authors:  A Das
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more
  1 in total

Review 1.  Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers.

Authors:  Mohammad Saeid Rezaee-Zavareh; Hamidreza Karimi-Sari; Fardin Dolatimehr; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2015-12-29       Impact factor: 0.660

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.